# EDGAR Filing Document

**Accession Number:** 0001620737
**File Stem:** 0001628280-25-041464
**Filing Date:** 2025-9
**Character Count:** 12244
**Document Hash:** 8935bc7d65e4f7da72d542b37bcca4cc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-25-041464.hdr.sgml**: 20250902

**ACCESSION NUMBER**: 0001628280-25-041464

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20250902

**FILED AS OF DATE**: 20250902

**DATE AS OF CHANGE**: 20250902

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ORGANIGRAM GLOBAL INC.
- **CENTRAL INDEX KEY:** 0001620737
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** Z4
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38885
- **FILM NUMBER:** 251284605

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 1400-145 KING ST. WEST
- **CITY:** TORONTO
- **PROVINCE COUNTRY:** A6
- **ZIP:** M5H 1J8
- **BUSINESS PHONE:** 506-232-4400

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 1400-145 KING ST. WEST
- **CITY:** TORONTO
- **PROVINCE COUNTRY:** A6
- **ZIP:** M5H 1J8

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ORGANIGRAM HOLDINGS INC.
- **DATE OF NAME CHANGE:** 20160831

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ORGANIGRAM HOLDINGS INC
- **DATE OF NAME CHANGE:** 20140926

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934**

For the month of September 2025

Commission File Number: **<u>001-38885</u>**

**<u>ORGANIGRAM GLOBAL INC.</u>**

(Translation of registrant's name into English)

**145 King Street West, Suite 1400**

**<u>Toronto, Ontario ,Canada M5H 1J8</u>**

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F [ ]&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Form 40-F [ X ]**

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ]

------

**SUBMITTED HEREWITH**

**<u>Exhibits</u>**

<u>[99.1](pressrelease-september 2202.htm)</u> Press release dated September 2, 2025 <br>

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

**ORGANIGRAM GLOBAL INC.**

<u>/s/ Greg Guyatt</u> 

Greg Guyatt

Chief Financial Officer

Date: September 2, 2025

## Exhibit 99.1

**Organigram Global Releases Landmark Report: Legal Cannabis Added $16B to Canada's GDP in 2024**

![image_0a.jpg](image_0a.jpg)

***New analysis shows cannabis as a national growth engine, aligning with Prime Minister Carney's One Canadian Economy vision.***

**TORONTO, Ontario September 2, 2025** – Organigram Global Inc. **(NASDAQ: OGI) (TSX: OGI)**, Canada's largest cannabis company by market share, today released "High Impact, Green Growth: The Economic Footprint of Canada's Cannabis Industry," a national report done in partnership with the Business Data Lab at the Canadian Chamber of Commerce. The report, which examined figures for 2024, underscores the legal cannabis sector's role as a major driver of jobs, economic growth, and innovation, highlighting why it should be included as a pillar of Prime Minister Mark Carney's *One Canadian Economy* vision.

The report shows that in 2024 Canada's legal cannabis industry contributed more than **$16 billion to national GDP**, generating **nearly $29 billion in total economic output**. To put its economic weight in perspective, cannabis's direct GDP contribution of $8.4 billion in 2024 exceeds that of forestry and logging ($3.4 billion), breweries ($2.6 billion), and wineries and distilleries ($975 million)<sup>1</sup>. The sector also supported **over 227,000 jobs across the country**, including **168,000 direct jobs in cultivation and retail**, alongside **59,000 in supply, logistics and professional services**. These contributions extend coast-to-coast, demonstrating cannabis's place as one of Canada's most significant homegrown industries.

"The legal cannabis sector is a high-value industry that is already delivering what the Prime Minister's *One Canadian Economy* vision calls for: a nationally integrated, high-value industry that's built in Canada, employing Canadians, and competing globally," stated Beena Goldenberg, CEO of Organigram Global. "With bold national leadership, we can secure Canada's place as the world's cannabis leader; a driver of national economic resilience within the *One Canadian Economy* vision."

<sup>1</sup> Statistics Canada. (2024). *Gross domestic product (GDP) at basic prices, by industry, annual average, industry detail* (Table 36-10-0434-06). Retrieved from https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=3610043406&pickMembers%5B0%5D=2.1&pickMembers%5B1%5D=3.1&cubeTimeFrame.startYear=2024&cubeTimeFrame.endYear=2024&referencePeriods=20240101%2C20240101

------

Andrew DiCapua, Principal Economist with the Canadian Chamber of Commerce's Business Data Lab and author of *High Impact, Green Growth,* reinforced this point, noting:

"Canada's legal cannabis industry has a major economic footprint in Canada. It is not only an emerging, domestic, sector that has created and sustained hundreds of thousands of jobs nationwide, but one with economic impacts felt coast-to-coast through the vast cannabis supply chain. This is precisely the type of industry that fits within the *One Canadian Economy* vision."

While the report focuses on cannabis's overall economic footprint in 2024, its scale is striking when compared to traditional Canadian agricultural commodities. For example, legal cannabis is now New Brunswick's most valuable crop, with farm cash receipts hitting $269.4 million in 2022, more than potatoes and dairy<sup>2</sup>. According to Agriculture and Agri-Food Canada, between 2020 and 2024, cannabis has averaged about $232 million annually in farm receipts, further underscoring its key role as New Brunswick's leading agricultural product<sup>3</sup>. Nationally, cannabis generated $2.7 billion in farm cash receipts in 2024, outmatching greenhouse vegetables ($2.63 billion) and field vegetables ($2.44 billion)<sup>4</sup>.

Yet, despite its outsized impact on Canada's economy last year, and the significant export potential of Canada's global first-mover advantage, outdated policy frameworks are preventing the sector from realizing its full potential. The current excise tax structure is designed around outdated pricing models, which limits innovation and growth. Moreover, the absence of a national export strategy is preventing Canada from capitalizing on an international cannabis market projected to surpass CAD $140 billion by 2026<sup>5</sup>, putting Canada on the backfoot of export diversification and international market development.

"We've built innovative, world-class cannabis production right here in Canada," concluded Ms. Goldenberg, "If Canada is serious about building the strongest economy in the G7, then industries like cannabis, which is already a $16 billion engine of jobs and innovation, must be a pillar of the *One Canadian Economy* strategy. It's time to modernize the rules, eliminate unnecessary barriers and unfair taxation, and give this industry the same opportunity to thrive as other strategic sectors."

**<u>About Organigram</u>**

Organigram Global Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. Through its acquisition of Collective Project Limited, Organigram Global participates in the U.S. and Canadian cannabinoid beverage markets.

Organigram is focused on producing high-quality cannabis for adult consumers, as well as developing international business partnerships to extend the Company's global footprint.

<sup>2</sup> Government of New Brunswick. (2023). *Agriculture* & agri-food review 2022 (NZ-00989). https://www2.gnb.ca/content/dam/gnb/Departments/10/pdf/Publications/Agr/review-agriculture-2022.pdf

<sup>3</sup> Agriculture and Agri-Food Canada. *Overview of Canada's agr*iculture and agri-food sector. https://agriculture.canada.ca/en/sector/overview?utm_source

<sup>4</sup> Statistics Canada. (2025, February 28). *Farm cash receipts of selected commodities, Canada: January–December 2024 (Table 1) [Data table]. Government of Canada. https://www150.statcan.gc.ca/n1/daily-quotidien/250228/t001d-eng.htm*

<sup>5</sup> Prohibition Partners. (2022). *The Global Cannabis Report: 3rd Edition* [Industry repo*rt]. https://prohibitionpartners.com/reports/the-global-cannabis-report-edition-3/*

------

Organigram has also developed and acquired a portfolio of cannabis brands, including Edison, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Collective Project, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. The Company also operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London will be optimized for labelling, packaging, and national fulfillment. The Company is regulated by Health Canada under the Cannabis Act and the Cannabis Regulations (Canada).

**<u>Forward-Looking Information</u>**

This news release contains forward-looking information. Often, but not always, forwardlooking information can be identified by the use of words such as "plans", "expects", "estimates", "intends", "anticipates", "believes" or variations of such words and phrases or state that certain actions, events, or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release.

Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include regulatory changes, consumer demand and preferences and factors and risks disclosed in the Company's most recent annual information form, management's discussion and analysis and other Company documents filed from time to time on SEDAR+ (see www.sedarplus.ca) and filed or furnished to the Securities and Exchange Commission on EDGAR (see www.sec.gov).

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release is made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

**<u>For Media enquiries:</u>** 

Mark McKay – Director of Communications <br>mark.mckay@organigram.ca

<br>